1don MSN
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.
The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...
BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy ...
Vivtex, cofounded by renowned MIT professor Robert Langer, stands to make as much as $2.1 billion if milestones are met.
GLP-1 medications have changed the conversation around weight management and metabolic health. When prescribed appropriately, ...
Creative Bloq on MSN
Honor unveils world's thinnest tablet (at just 4.8mm)
The MagicPad4 sounds sensational, and I can't wait to try it.
Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal worth up to $2.1 billion ...
Novo Nordisk stock fell over 16% Monday after it said its next-generation weight loss drug didn't meet its primary target.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results